Related Experiment Video
Updated: Jan 30, 2026
Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
Published on: February 22, 2019
MiT transcription factor associated malignancies in man
1Division of Hematology/Oncology, Department of Pediatrics, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599-7295, USA. ian_davis@med.unc.edu
Abstract:
The discovery of recurrent genetic abnormalities in cancer cells has often led to the identification of novel oncogenic genes and gene families. The nature of these alterations may also offer insights into the mechanisms by which these genes mediate their oncogenic role. Amplification, translocation, deletion and point mutation are common mechanisms that result in gain- or loss-of-function of cancer associated genes. Several studies have recently demonstrated multiple genetic strategies that ultimately converge to dysregulate members of the MiT transcription factor family in cancer. The shared dependence on aberrant MiT activity thus defines an expanding family of human solid tumors.
Insights
Recurrent genetic changes in cancer cells reveal new oncogenes. Aberrant activity of MiT transcription factors is a common mechanism driving multiple human solid tumors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Recurrent genetic abnormalities in cancer cells frequently identify novel oncogenic genes.
- Understanding these alterations provides insights into oncogenic mechanisms.
- Common genetic alterations include amplification, translocation, deletion, and point mutation, affecting gene function.
Purpose of the Study:
- To investigate the role of MiT transcription factors in cancer.
- To identify common genetic strategies leading to MiT family dysregulation in solid tumors.
- To define a family of human solid tumors based on shared dependence on aberrant MiT activity.
Main Methods:
- Analysis of genetic abnormalities in cancer cells.
- Review of recent studies on MiT transcription factor family dysregulation.
- Identification of convergent genetic strategies impacting MiT activity.
Main Results:
- Multiple genetic strategies converge to dysregulate MiT transcription factor family members in cancer.
- Aberrant MiT activity is a shared characteristic across an expanding group of human solid tumors.
Conclusions:
- Dysregulation of the MiT transcription factor family is a key mechanism in a growing number of human solid tumors.
- Identifying shared oncogenic pathways, like aberrant MiT activity, can define new therapeutic strategies for cancer treatment.
More Related Videos
Related Concept Videos
02:16Transcription Factors
02:35Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
02:35Transcription Elongation Factors
01:30General Transcription Factors
01:10Transcription
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...
02:23Master Transcription Regulators